ORIC Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €55.66M +154.9% -€182.02M +17.3% -327.0% +3.8 pp N/A N/A
    (estimated) €21.84M +725.8% -€155.19M +10.0% -710.7% +46 pp N/A N/A
    (estimated) €2.64M +∞% -€141.10M +9.1% -5,336.5% -53 pp -€105.80M -2.9% -4,001.3% -40 pp
    (estimated) €0.00 +NaN% -€129.38M +9.5% N/A -€109.01M -10.9% N/A
    (estimated) €0.00 +NaN% -€118.12M +8.3% N/A -€122.31M +27.3% N/A
    €0.00 +NaN% -€109.05M +27.0% N/A -€96.10M +32.8% N/A
    €0.00 +NaN% -€85.89M +10.1% N/A -€72.36M +16.1% N/A
    €0.00 +NaN% -€78.03M +17.8% N/A -€62.32M +24.7% N/A
    €0.00 +NaN% -€66.25M -20.1% N/A -€49.98M +31.4% N/A
    €0.00 +NaN% -€82.97M +281.7% N/A -€38.04M +95.9% N/A
    €0.00 +NaN% -€21.74M +19.3% N/A -€19.42M +12.9% N/A
    €0.00 +NaN% -€18.22M -3.0% N/A -€17.19M -0.9% N/A
    €0.00 -€18.79M N/A -€17.35M N/A

    Notifications